CureVac GAAP EPS of Euro1.21, revenue of Euro54.13M
Source: SeekingAlpha
2025-11-24 07:46:56 ET
More on CureVac BV
- CureVac: The Hidden Value Of The mRNA Wallet
- Seeking Alpha’s Quant Rating on CureVac BV
- Historical earnings data for CureVac BV
- Financial information for CureVac BV
Read the full article on Seeking Alpha
For further details see:
CureVac GAAP EPS of €1.21, revenue of €54.13M
CureVac N.V.
NASDAQ: CVAC
CVAC Trading
-14.23% G/L:
$4.64 Last:
558,418 Volume:
$4.57 Open:
CVAC Latest News
November 24, 2025 07:30:00 am
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2025 and Provides Business Updates
CVAC Stock Data
$1,045,416,278
124,238,526
N/A
39
N/A
Biotechnology & Life Sciences
Healthcare
DE
Tübingen
